Results 151 to 160 of about 13,658,162 (350)
Review of Particle Physics
, 2014 K. Olive, K. Agashe, C. Amsler, M. Antonelli, J. Arguin, D. Asner, H. Baer, H. Band, R. Barnett, T. Basaglia, C. Bauer, J. Beatty, V. L. Belousov, J. Beringer, G. Bernardi, S. Bethke, H. Bichsel, O. Biebel, E. Blucher, S. Blusk, G. Brooijmans, O. Buchmueller, V. Burkert, M. Bychkov, R. Cahn, M. Carena, M. Carena, A. Ceccucci, A. Cerri, D. Chakraborty, Mu-Chun Chen, R. Chivukula, K. Copie, G. Cowan, O. Dahl, G. D’Ambrosio, T. Damour, D. Florian, A. Gouvea, T. DeGrand, P. Jong, G. Dissertori, B. Dobrescu, M. Doser, M. Drees, H. Dreiner, D. A. Edwards, S. Eidelman, J. Erler, J. Erler, V. Ezhela, W. Fetscher, B. Fields, B. Foster, B. Foster, A. Freitas, T. Gaisser, H. Gallagher, L. Garren, H. Gerber, G. Gerbier, T. Gershon, T. Gherghetta, S. Golwala, M. Goodman, C. Grab, A. Gritsan, C. Grojean, D. Groom, M. Grunewald, M. Grunewald, A. Gurtu, A. Gurtu, T. Gutsche, H. Haber, H. Haber, K. Hagiwara, C. Hanhart, S. Hashimoto, Y. Hayato, K. Hayes, M. Heffner, B. Heltsley, J. Hernández-Rey, K. Hikasa, A. Höcker, J. Holder, A. Holtkamp, J. Huston, J. Jackson, K. F. Johnson, T. Junk, M. Kado, M. Kado, D. Karlen, U. Katz, S. Klein, E. Klempt, R. Kowalewski, F. Krauss, M. Kreps, B. Krusche, Yu. V. Kuyanov, Y. Kwon, O. Lahav, J. Laiho, P. Langacker, A. Liddle, Z. Ligeti, Chen Lin, T. Liss, L. Littenberg, K. S. Lugovsky, S. Lugovsky, F. Maltoni, T. Mannel, A. Manohar, W. Marciano, Alan D. Martin, A. Masoni, J. Matthews, D. Milstead, P. Molaro, K. Mönig, F. Moortgat, M. Mortonson, M. Mortonson, H. Murayama, H. Murayama, Hitoshi Murayama, Kei Nakamura, M. Narain, P. Nason, S. Navas, M. Neubert, P. Nevski, Y. Nir, L. Pape, J. Parsons, C. Patrignani, J. Peacock, M. Pennington, S. Petcov, S. Petcov, A. Piepke, A. Pomarol, A. Quadt, S. Raby, J. Rademacker, G. Raffelt, B. Ratcliff, P. Richardson, A. Ringwald, S. Roesler, S. Rolli, A. Romaniouk, L. Rosenberg, J. Rosner, G. Rybka, C. Sachrajda, Y. Sakai, G. Salam, G. Salam, S. Sarkar, S. Sarkar, F. Sauli, O. Schneider, K. Scholberg, D. Scott, V. Sharma, S. Sharpe, M. Silari, T. Sjöstrand, P. Skands, P. Skands, J. Smith, G. Smoot, G. Smoot, G. Smoot, S. Spanier, H. Spieler, C. Spiering, A. Stahl, T. Stanev, S. Stone, T. Sumiyoshi, M. Syphers, F. Takahashi, M. Tanabashi, J. Terning, L. Tiator, M. Titov, N. P. Tkachenko, N. Tornqvist, D. Tovey, G. Valencia, G. Venanzoni, M. Vincter, P. Vogel, A. Vogt, S. Wakely, W. Walkowiak, C. Walter, D. Ward, G. Weiglein, D. Weinberg, E. Weinberg, M. White, M. White, L. Wiencke, C. Wohl, L. Wolfenstein, J. Womersley, C. Woody, R. Workman, A. Yamamoto, W. Yao, G. Zeller, O. Zenin, Jiayu Zhang, R. Zhu, F. Zimmermann, P. Żyła, G. Harper, V. S. Lugovsky, P. Schaffner +225 moresemanticscholar +1 more sourceExosome Proteomics of SOD1D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease. Super oxide dismutase 1 (SOD1) gene mutations cause ALS, and the D90A mutation is associated with primarily upper motor neuron (UMN) loss. Objective
Our goal is to reveal the early cellular events in ALS pathology and identify potential pharmacokinetic biomarkers, using well ...Mukesh Gautam, Ali Laith, Aslihan Gunel, Melda Yilmaz, Nazli Basak, Halil Idrisoglu, P. Hande Ozdinler +6 morewiley +1 more sourceReview of Particle Physics: Particle data group
, 2012 K. Hagiwara, K. Hikasa, Kei Nakamura, M. Tanabashi, M. Aguilar-Benitez, C. Amsler, R. Barnett, P. Burchat, C. Carone, C. Caso, G. Conforto, O. Dahl, M. Doser, S. Eidelman, Jonathan L. Feng, L. Gibbons, M. Goodman, C. Grab, D. Groom, A. Gurtu, K. Hayes, J. Hernández-Rey, K. Honscheid, C. Kolda, M. Mangano, D. Manley, A. Manohar, J. March-Russell, A. Masoni, R. Miquel, K. Mönig, H. Murayama, S. Navas, K. Olive, L. Pape, C. Patrignani, A. Piepke, M. Roos, J. Terning, N. Tornqvist, T. Trippe, P. Vogel, C. Wohl, R. L. Workman, W. Yao, B. Armstrong, P. S. Gee, K. S. Lugovsky, S. Lugovsky, V. S. Lugovsky, M. Artuso, D. Asner, K. S. Babu, E. Barberio, M. Battaglia, H. Bichsel, O. Biebel, P. Bloch, R. Cahn, A. Cattai, R. Chivukula, R. Cousins, G. Cowan, T. Damour, K. Desler, R. J. Donahue, D. Edwards, V. Elvira, J. Erler, V. Ezhela, A. Fassò, W. Fetscher, B. Fields, B. Foster, D. Froidevaux, M. Fukugita, T. Gaisser, L. Garren, H. Gerber, F. J. Gilman, H. Haber, C. Hagmann, J. Hewett, I. Hinchliffe, C. Hogan, G. Höhler, P. Igo-Kemenes, J. Jackson, K. Johnson, D. Karlen, B. Kayser, S. Klein, K. Kleinknecht, I. Knowles, P. Kreitz, Yu. V. Kuyanov, R. Landua, P. Langacker, L. Littenberg, Alan D. Martin, T. Nakada, M. Narain, P. Nason, J. Peacock, H. Quinn, S. Raby, G. Raffelt, E. Razuvaev, B. Renk, L. Rolandi, M. Ronan, L. Rosenberg, C. Sachrajda, A. Sanda, S. Sarkar, M. Schmitt, O. Schneider, D. Scott, W. Seligman, M. Shaevitz, T. Sjöstrand, G. Smoot, S. Spanier, H. Spieler, N. Spooner, M. Srednicki, A. Stahl, T. Stanev, M. Suzuki, N. P. Tkachenko, G. Valencia, K. Bibber, M. Vincter, D. Ward, B. Webber, M. Whalley, L. Wolfenstein, J. Womersley, C. Woody, O. Zenin +139 moresemanticscholar +1 more sourceInterleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi +13 morewiley +1 more sourcePhysics of E × B discharges relevant to plasma propulsion and similar technologies [PDF]
, 2020 Igor D. Kaganovich, Andrei Smolyakov, Yevgeny Raitses, Eduardo Ahedo, Ioannis G. Mikellides, Benjamin Jorns, Francesco Taccogna, Renaud Gueroult, Sedina Tsikata, Anne Bourdon, Jean-Pierre Boeuf, Michael Keidar, Andrew Tasman Powis, Mario Merino, Mark Cappelli, Kentaro Hara, Johan A. Carlsson, Nathaniel J. Fisch, Pascal Chabert, Irina Schweigert, Trevor Lafleur, Konstantin Matyash, Alexander V. Khrabrov, Rod W Boswell, Amnon Fruchtman +24 moreopenalex +1 more sourceSNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez +18 morewiley +1 more source
